HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Massaia Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

1/2018Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Massaia Research Topics

Disease

24Neoplasms (Cancer)
02/2024 - 07/2006
14Multiple Myeloma
12/2023 - 06/2004
12B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2024 - 10/2012
7Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 10/2010
5COVID-19
02/2023 - 01/2022
4Infections
01/2022 - 08/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022 - 04/2007
3Lymphoma (Lymphomas)
12/2022 - 01/2018
2Hemorrhage
07/2023 - 10/2018
2Hodgkin Disease (Hodgkin's Disease)
03/2021 - 10/2017
2Paraproteinemias (Monoclonal Gammopathy)
06/2020 - 12/2004
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2020 - 10/2018
2Hypoxia (Hypoxemia)
01/2020 - 01/2013
2Monoclonal Gammopathy of Undetermined Significance
01/2018 - 09/2007
2Anemia
09/2007 - 06/2004
1Colorectal Neoplasms (Colorectal Cancer)
02/2024
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2023
1Hemophilia A (Haemophilia)
07/2023
1Residual Neoplasm
01/2023
1Plasma Cell Neoplasms
12/2022
1Coinfection
12/2022
1Thrombotic Thrombocytopenic Purpura
01/2022
1Hematologic Diseases (Blood Diseases)
06/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Critical Illness (Critically Ill)
07/2019
1Bacterial Infections (Bacterial Infection)
07/2019
1Communicable Diseases (Infectious Diseases)
07/2019
1Triple Negative Breast Neoplasms
11/2018
1Breast Neoplasms (Breast Cancer)
11/2018
1Atrial Fibrillation
10/2018
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2018
1Leukemia
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1Cardiotoxicity
10/2017
1Disease Progression
01/2017

Drug/Important Bio-Agent (IBA)

5Rituximab (Mabthera)FDA Link
01/2023 - 05/2014
4Proteins (Proteins, Gene)FDA Link
02/2024 - 12/2004
4Mevalonic Acid (Mevalonate)IBA
09/2013 - 12/2010
3CytokinesIBA
01/2023 - 01/2018
3VaccinesIBA
11/2022 - 08/2007
3Immunoglobulin M (IgM)IBA
06/2020 - 09/2007
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2020 - 10/2015
3Bortezomib (Velcade)FDA Link
11/2018 - 03/2008
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018 - 01/2013
3Zoledronic Acid (Zometa)FDA Link
01/2018 - 12/2010
2ibrutinibIBA
03/2024 - 10/2018
2CalreticulinIBA
02/2024 - 11/2018
2Monoclonal AntibodiesIBA
12/2023 - 11/2023
2Bendamustine HydrochlorideFDA Link
10/2023 - 09/2014
2AutoantibodiesIBA
07/2023 - 01/2022
2venetoclaxIBA
01/2023 - 01/2022
2hydroxyethyl methacrylate (HEMA)IBA
12/2022 - 12/2022
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2020 - 06/2004
2fludarabineIBA
01/2020 - 10/2015
2Messenger RNA (mRNA)IBA
01/2020 - 12/2004
2Immunoglobulin E (IgE)IBA
07/2019 - 09/2007
2Proteasome Endopeptidase Complex (Proteasome)IBA
11/2018 - 03/2008
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2018 - 01/2013
2AntigensIBA
01/2017 - 07/2006
2Chlorambucil (Leukeran)FDA Link
01/2017 - 05/2014
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2015 - 10/2012
2LigandsIBA
10/2012 - 07/2011
2Peptides (Polypeptides)IBA
08/2011 - 11/2007
2Immunoglobulins (Immunoglobulin)IBA
09/2007 - 07/2006
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
02/2024
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2024
1carfilzomibIBA
02/2024
1HMGB1 Protein (HMG1)IBA
02/2024
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2024
1daratumumabIBA
11/2023
1Blood Coagulation Factors (Coagulation Factor)IBA
07/2023
1ribonucleotide polymeraseIBA
01/2023
1Pregnenolone Carbonitrile (PCN)IBA
12/2022
1caplacizumabIBA
01/2022
1ADP-ribosyl CyclaseIBA
10/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2021
1dichlorobis(azomycin)platinum IIIBA
03/2021
1AntibodiesIBA
01/2021
1Hypoxia-Inducible Factor 1IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1Intravenous Immunoglobulins (IVIG)FDA Link
07/2019
1Chloroquine (Aralen)FDA LinkGeneric
11/2018
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2018
1NitritesIBA
11/2018
1Agammaglobulinaemia Tyrosine KinaseIBA
10/2018
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2018
1AnticoagulantsIBA
10/2018
1indolepropanol phosphate (IPP)IBA
01/2018
1Bispecific AntibodiesIBA
01/2018
1Pentostatin (Nipent)FDA LinkGeneric
12/2015
1ofatumumabFDA Link
12/2015

Therapy/Procedure

15Therapeutics
12/2023 - 06/2004
7Immunotherapy
01/2023 - 07/2006
5Drug Therapy (Chemotherapy)
01/2022 - 07/2006
3Stem Cell Transplantation
01/2018 - 11/2007
3Transplantation
01/2016 - 04/2006
1Intravenous Administration
02/2024
1Anesthesia
07/2019
1Critical Care (Surgical Intensive Care)
07/2019